ICIS Top 100 Chemical Companies ranking unveiled with BASF back on top

Operating profits among the ICIS Top 100 chemical companies fell 47.3% in 2025 on a 4.6% sales decline, while net profits collapsed 81.9%, reflecting China-led petrochemical overcapacity and weak housing, automotive and durable-goods demand. BASF regained the top ranking with $70.0 billion in sales, ahead of Sinopec at $66.3 billion and ExxonMobil at $53.4 billion. ICIS expects 2025 to mark the earnings-cycle bottom, with potentially meaningful 2026 margin recovery as Middle East conflict-related chemical and feedstock shortages tighten supply.

Analysis

The investable question is not whether chemical pricing rises, but whether product-price gains outrun naphtha, gas and logistics inflation. BASF's earnings torque is high after a trough, yet its European asset base leaves it more exposed than US peers to energy-cost pass-through failure; a disruption-led price spike is therefore less cleanly bullish than a demand-led recovery. BAS.DE should outperform only if European ethylene/polymer spreads widen, rather than merely if crude and gas rise.

China's capacity additions create a ceiling on any broad petrochemical rerating: export volumes can redirect toward Europe and Asia once logistics normalize, compressing the duration of a shortage premium. This favors companies with differentiated downstream portfolios and low-cost feedstock integration—LYB and WLK—over more commodity-exposed European producers. XOM is a weak direct expression of a chemicals recovery because upstream gains can offset chemical-margin pressure, leaving consolidated earnings less sensitive to the relevant spread.

Over the next days, geopolitical risk may lift chemical equities indiscriminately, but the 1-3 month catalyst is independently observable contract-price and utilization data, alongside BASF's volume guidance. A 6-18 month recovery requires housing, autos and industrial demand to absorb Chinese supply; absent that, an inventory restock can be mistaken for a cycle turn and multiples will fade after initial earnings beats. RELX has no meaningful earnings sensitivity to this industry cycle; the ranking publication is not a catalyst for the stock.

Key Decisions for Investors

• Watch, rather than chase, BAS.DE on disruption headlines; initiate a 3-6 month long only after European ethylene or key polymer spreads expand for 4-6 consecutive weeks and management confirms volume stabilization. Falsify on renewed negative EBITDA guidance or a failure of product pricing to recover relative to European gas/naphtha costs.
• Express a cleaner recovery through long LYB versus short BAS.DE over 3-6 months if energy/feedstock volatility remains elevated: LYB's US feedstock position and shareholder-return capacity should defend downside better. Exit if Chinese export pricing rises materially or US ethane advantage narrows enough to erase the feedstock-cost differential.
• Maintain an underweight/short bias in XOM's chemicals sensitivity rather than shorting XOM outright; pair a modest long XLE with short XLB if energy prices rise while downstream margins remain constrained. The pair is invalidated by a broad demand rebound that lifts chemical spreads faster than oil.
• Set an alert around BASF's next quarterly volume, fixed-cost and free-cash-flow outlook: a volume-led improvement, not just higher nominal selling prices, would justify upgrading the recovery probability and closing the BAS.DE leg of the relative-value trade.